Gewählte Publikation:
Weger, M; Stanger, O; Deutschmann, H; Simon, M; Renner, W; Schmut, O; Semmelrock, J; Haas, A.
Hyperhomocyst(e)inaemia, but not MTHFR C677T mutation, as a risk factor for non-arteritic ischaemic optic neuropathy.
Br J Ophthalmol. 2001; 85(7):803-806
Doi: 10.1136%2Fbjo.85.7.803
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Weger Martin
- Co-Autor*innen der Med Uni Graz
-
Deutschmann Hannes
-
Haas Anton
-
Renner Wilfried
-
Schmut Otto
-
Semmelrock Hans-Jürgen
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND/AIMS: Hyperhomocyst(e)inaemia has been identified as a strong risk factor for stroke, myocardial infarction, and deep vein thrombosis. A point mutation of methylene tetrahydrofolate reductase (MTHFR C677T) has been associated with increased plasma homocyst(e)ine levels. To investigate whether hyperhomocyst(e)inaemia and/or MTHFR C677T mutation are associated with non-arteritic ischaemic optic neuropathy (NAION), a case-control study including 59 consecutive patients with NAION and 59 controls matched for age and sex was performed. METHODS: Fasting plasma homocyst(e)ine levels, MTHFR C677T genotypes, and plasma levels of folate and vitamin B-12 were determined. RESULTS: Mean plasma homocyst(e)ine levels were significantly higher in patients than in controls (11.8 (SD 5.7) micromol/l v 9.8 (2.5) micromol/l, p = 0.02). The odds ratio for patients with homocyst(e)ine levels exceeding the 95th percentile of control homocyst(e)ine levels was 5.8 (95% CI 1.5-21.4). Mean plasma folate levels were significantly lower in patients than in controls (4.3 (1.7) ng/ml v 5.5 (1.9) ng/ml, p = 0.001), whereas plasma vitamin B-12 levels did not differ significantly. Prevalence of the MTHFR C677T mutation was not significantly increased in patients with NAION compared with controls. CONCLUSION: These results suggest that hyperhomocyst(e)inaemia, but not MTHFR C677T mutation is associated with NAION. Determination of plasma homocyst(e)ine levels might be of diagnostic value in patients with NAION.
- Find related publications in this database (using NLM MeSH Indexing)
-
Aged -
-
Aged, 80 and over -
-
Biological Markers - blood
-
Case-Control Studies - blood
-
Female - blood
-
Folic Acid - blood
-
Humans - blood
-
Hyperhomocysteinemia - blood
-
Male - blood
-
Methylenetetrahydrofolate Reductase (NADPH2) - blood
-
Middle Aged - blood
-
Optic Neuropathy, Ischemic - blood
-
Oxidoreductases Acting on CH-NH Group Donors - genetics
-
Point Mutation - genetics
-
Risk Factors - genetics
-
Vitamin B 12 - blood